Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
chlorhexidine + ethyl alcohol
- Development stage
- Phase 4
- Lead developer
- Denteck
- Modality
- Small Molecules
- Administration
- Topical
01
Overview
Chlorhexidine + ethyl alcohol is an antiseptic combination used primarily for skin disinfection. The formulation typically contains chlorhexidine gluconate 0.5% w/v in ethyl alcohol 70% v/v. This combination provides both immediate and sustained antimicrobial activity, with ethyl alcohol delivering rapid bacterial reduction while chlorhexidine provides prolonged antimicrobial effects. It is commonly used for surgical site preparation, healthcare provider hand disinfection, and skin preparation before invasive procedures.
- Brand names
- Avagard
- Other names
- Chlorhexidine digluconate 0.5% in Alcohol 70%Chlorhexidine/ethanol
Beyond the preview
Go deeper on chlorhexidine + ethyl alcohol.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on chlorhexidine + ethyl alcohol.